Catabasis Pharmaceuticals Inc. (CATB) Gained 5.14% or 0.22 To Price $4.5 On Tuesday


Catabasis Pharmaceuticals Inc. (CATB) gained 5.14% or 0.22 to $4.5. It is about 67677 shares traded, which is 34.05% compare to the average total volume 198758. The market cap of CATB is $33.73 million. The year to date change is 1.75%. The 52 week price range is from $3.6 to $21.8. Price of CATB have changed -4.04% during last week. It have changed -20.15% over last month, -33.64% over last 3 months, -34.46% over last 6 months and -65.76% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CATB is 5.40. It is 20.00% above current price. The 200-day Moving Averages for CATB is 8.38. It is 86.22% above current price. The 52-week High is 21.8. It is 384.44% from the current price. The 52-week Low is 3.6. It is -20.00% from current price.

There are some statistics of CATB. It is has market cap $33.73 million. The share outstanding is 7.50 million. The average volume is 198758. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CATB is -90.36%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CATB is -74.68%.


Tags:

Share this post